Carlos Slim Pemex Crisis Poses Mexicos Most Pressing Economic Challenge LSAK Q1 2026 Earnings Massive EPS Beat Surprises Markets Innovent Biologics and Pfizer Announce Landmark Drug Deal Valued at Up to 105 Billion KEX Q1 2026 Earnings EPS Surpasses Estimates by 66 Shares Edge Lower ETSY Q1 2026 Earnings EPS Surges Past Estimates as Cost Discipline Drives Beat SIEB Q4 2025 Earnings Narrow Loss Amid Challenging Market Conditions BLBD Q1 2026 Earnings EPS Beats Estimates by Nearly 11 Amid Mixed Market Reaction NESR Q1 2026 Earnings EPS Beats Estimates by Nearly 20 Despite Limited Revenue Disclosure RNG Q1 2026 Earnings EPS Surprise Drives Stock Uptick TRINI Q1 2026 Earnings EPS Surpasses Estimates by 116 Stock Unchanged